DDX53 and cancer: Notably, pTRG completely prevented the second challenge-induced cancer growth in the lungs of mice cured of the first CT-26 challenge, whereas TRG-cured mice showed CT-26 tumor cell infiltration in the lungs (Fig. 4B, C).